“Shares of Eastman Kodak plunged more than 40% at the low on Monday after a federal agency said it was reviewing a previously announced $765 million loan for the onetime photography pioneer to produce drug ingredients. “Recent allegations of wrongdoing raise serious… Continue Reading…